Review
Novel serotonergic agents
Affiliations
- PMID: 8400010
Item in Clipboard
Review
Novel serotonergic agents
Drug Des Discov.
1993.
Abstract
The preliminary structure-activity relationships are described for a series of substituted phenethylamines that induce the release of neuronal serotonin. Structures that also have the ability to release neuronal catecholamines are toxic to serotonin neurons, leading to long-term reductions in serotonin markers in rat brain. Conversely, compounds that are selective for the serotonin uptake carrier, and do not affect catecholamines, are not neurotoxic. It is suggested that these novel, selective serotonin releasing agents may find therapeutic utility in disorders where serotonin uptake inhibitors are currently employed.
Similar articles
-
Serotonin receptors and therapeutics.Cell Mol Biol (Noisy-le-grand). 1994 May;40(3):327-36. Cell Mol Biol (Noisy-le-grand). 1994. PMID: 7522716 Review.
-
Harmane inhibits serotonergic dorsal raphe neurons in the rat.Psychopharmacology (Berl). 2005 Nov;182(4):562-9. doi: 10.1007/s00213-005-0118-0. Epub 2005 Oct 19. Psychopharmacology (Berl). 2005. PMID: 16133137
-
The structure-activity relationship of inhibitors of serotonin uptake and receptor binding.J Comput Aided Mol Des. 1991 Oct;5(5):441-53. doi: 10.1007/BF00125664. J Comput Aided Mol Des. 1991. PMID: 1770380
-
Synthesis and molecular modeling of new 1-aryl-3-[4-arylpiperazin-1-yl]-1-propane derivatives with high affinity at the serotonin transporter and at 5-HT(1A) receptors.J Med Chem. 2002 Sep 12;45(19):4128-39. doi: 10.1021/jm0111200. J Med Chem. 2002. PMID: 12213056
-
Drugs affecting 5-hydroxytryptamine function.Drug Ther Bull. 1993 Mar 29;31(7):25-7. Drug Ther Bull. 1993. PMID: 8344147 Review. No abstract available.
Cited by
-
Predicting monoamine oxidase inhibitory activity through ligand-based models.Curr Top Med Chem. 2012;12(20):2258-74. doi: 10.2174/156802612805219987. Curr Top Med Chem. 2012. PMID: 23231398 Free PMC article. Review.
-
Monoamine Oxidase (MAO) as a Potential Target for Anticancer Drug Design and Development.Molecules. 2021 Oct 4;26(19):6019. doi: 10.3390/molecules26196019. Molecules. 2021. PMID: 34641563 Free PMC article. Review.
-
Amphetamine Derivatives as Monoamine Oxidase Inhibitors.Front Pharmacol. 2020 Jan 23;10:1590. doi: 10.3389/fphar.2019.01590. eCollection 2019. Front Pharmacol. 2020. PMID: 32038257 Free PMC article. Review.
-
(+/-)-1-(2,5-Dimethoxy-4-ethylthiophenyl)-2-aminopropane (ALEPH-2), a novel putative anxiolytic agent lacking affinity for benzodiazepine sites and serotonin-1A receptors.Naunyn Schmiedebergs Arch Pharmacol. 1996 Nov;354(5):579-85. doi: 10.1007/BF00170831. Naunyn Schmiedebergs Arch Pharmacol. 1996. PMID: 8938655